# SEG Drug HTML Medical Closure Record

**Document ID:** `SEG_DRUG_HTML_MEDICAL_CLOSURE_RECORD`  
**Mode:** `OWNER GOVERNED MEDICAL CONTENT REVIEW`  
**Review pathway:** `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY`  
**Source:** Drug HTML  
**Ownership:** `SEG_INTERNAL_ASSET` for the declared retained artifact scope  
**Decision authority:** Dr. Alaa Al-Asfar — SEG Medical Content Owner; Emergency Medicine Physician; Project Lead  
**Clinical review date:** `NOT_SUPPLIED` — the execution timestamp of this record is not treated as a completed clinical-review date

## 1. Closure boundary

This record documents the available owner-governed assessment scope and the evidence-supported findings for the locked Drug HTML representation. It does not perform clinical reasoning in place of a completed attributable review, certify drug safety, confirm emergency-medicine relevance, or approve the source. No medication fact, dose, interaction, contraindication, safety statement, or metadata value was added or corrected.

## 2. Reviewed artifact and scope

| Field | Value | Status |
|---|---|---|
| Internal source identity | `LOCAL_INTAKE_ARTIFACT` | `CONFIRMED` for retained representation |
| Internal version identifier | `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` | `CONFIRMED` governance identifier |
| Artifact reference | `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html` | `CONFIRMED` |
| SHA-256 | `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac` | `CONFIRMED` |
| Scope examined | Internal metadata, retained structure, available field containers, clinical-field requirements, emergency relevance requirements, drug-safety requirements, and evidence limitations | `DOCUMENTED` |
| Review owner/authority | Dr. Alaa Al-Asfar | `CONFIRMED` by supplied owner declaration |
| Review identity/date evidence | Owner authority is identified; separate clinical-review date, credential evidence, conflict declaration, and completed domain review are `NOT_SUPPLIED` | `INCOMPLETE` |

The artifact reference and hash are linked to the metadata lock record and must remain unchanged for this closure decision.[1]

## 3. Evidence-supported positive findings

The following findings are limited to retained-artifact and governance evidence:

| Finding | Supported result | Boundary |
|---|---|---|
| Artifact continuity | Exact local artifact and SHA-256 are recorded | Does not establish source authority or clinical correctness |
| Internal version anchor | `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` is assigned to the retained representation | Does not represent a canonical publication edition or clinical currency |
| Structure | 19 `summaryData` sections, 21 `quick` entries, 47 `drugList` entities, and 20 `trapsList` entries are structurally observed | Does not establish completeness, safety, or medical validity |
| Review scope | Emergency-medicine relevance, information organization, safety, and metadata domains are defined | Domain definition is not domain completion |
| Controlled internal use | Internal educational-development scope and controlled access are declared | Does not authorize public display, redistribution, or learner-facing production |

## 4. Assessment by requested domain

### 4.1 Emergency-medicine relevance

The artifact contains emergency-oriented drug-information structures, but the available evidence does not support a completed clinical relevance determination. The following must still be examined for each applicable entity and section: indication, emergency context, intended population, exclusions, dose statements, contraindications, precautions, currency, omissions, ambiguity, conflicts, and exact source/entity locators.

**Assessment state:** `NOT_COMPLETED`  
**Decision implication:** Further attributable review required.

### 4.2 Drug information organization

The available structural inventory is sufficient to identify review scope and to anchor a future traceable assessment. It does not establish whether entity identity, formulation, concentration, route, dose, section boundaries, internal consistency, or source citations are complete or reliable.

**Assessment state:** `STRUCTURE_OBSERVED_REVIEW_INCOMPLETE`  
**Decision implication:** Structure may be used as a controlled review anchor only; it is not accepted as clinically validated organization.

### 4.3 Safety considerations

The available evidence does not support a completed drug-safety assessment. Required checks include drug identity, formulation and concentration, dose and units, route and administration, contraindications, precautions, interactions, duplicate therapy, adverse effects, monitoring, high-risk warnings, population limits, source currency, and exact safety references. No explicit pairwise interaction table was observed in the available artifact evidence; this is an observation only and is not evidence that interactions are absent.

**Assessment state:** `NOT_COMPLETED`  
**Decision implication:** A separate attributable Pharmacology/Drug Safety review remains required.

### 4.4 Missing critical fields

The following fields remain `NOT_ESTABLISHED` or `INCOMPLETE` pending review and evidence:

| Field group | Current state |
|---|---|
| Drug identity and disambiguation | `NOT_ESTABLISHED` |
| Formulation, concentration, route | `NOT_ESTABLISHED` |
| Dose, units, administration, maximums | `NOT_ESTABLISHED` |
| Contraindications and precautions | `NOT_ESTABLISHED` |
| Interactions and interaction references | `NOT_ESTABLISHED` |
| Adverse effects, toxicity, monitoring | `NOT_ESTABLISHED` |
| Emergency-medicine scope and learner-level suitability | `NOT_ESTABLISHED` |
| Currentness and protocol/reference alignment | `NOT_ESTABLISHED` |
| Entity/section/source/version locators | `INCOMPLETE` |
| Canonical source, version, provenance, rights, track, taxonomy | `NOT_AVAILABLE` or unresolved |

`NOT_ESTABLISHED` means that the current evidence is insufficient to decide whether the field is present, complete, current, or safe. It is not a clinical assertion that the field is absent.

### 4.5 Required corrections and dispositions

No correction is authorized or performed through this record. If a later authorized review identifies a critical issue, the required disposition must be recorded before any derivative is made:

1. Tie the finding to the exact artifact hash and entity/section locator.
2. Record whether the issue is an ambiguity, omission, contradiction, unsafe statement, outdated statement, metadata defect, or provenance/rights defect.
3. Escalate any medication fact, dose, interaction, contraindication, or safety issue to the appropriate owner-governed medical/drug-safety decision stream.
4. Preserve the original HTML and create any derivative only under separate authorization with a new version ID, SHA-256, change reason, authority, and audit event.
5. Record the disposition as unresolved, corrected under authorization, restricted, or otherwise explicitly decided by the attributable review authority; do not infer or silently repair.

## 5. Decision

**Owner decision:** `OWNER_REQUIRES_FURTHER_REVIEW`

The decision is based on the locked artifact and the documented structural/metadata evidence. The current record does not contain sufficient attributable clinical, drug-safety, canonical-source, provenance, rights, version, or metadata evidence to close the Drug HTML medical review. This is not a source rejection and does not grant source approval.

## 6. Remaining blockers

| Gate | State | Required evidence |
|---|---|---|
| Canonical source identity/version | `BLOCKED` | Source title, publisher/custodian, version/date, original locator |
| Provenance and extraction lineage | `BLOCKED` | Origin, transformation, extraction, recovery, and chain-of-custody evidence |
| Rights/display scope | `BLOCKED` | Rights or permission for retained and any incorporated third-party material |
| Emergency-medicine clinical validation | `BLOCKED` | Attributable dated review with exact entity/section locators and disposition |
| Pharmacology/Drug Safety validation | `BLOCKED` | Attributable dated review of medication safety fields and conflicts |
| Metadata/track/taxonomy validation | `BLOCKED` | Complete governed metadata and explicit track/taxonomy decision |
| Technical/HTML lineage review | `BLOCKED` | Representation and derivative-lineage assessment |
| Audit closure | `BLOCKED` | Append-only decision event linked to this record and exact artifact |
| Source-level approval | `NOT_GRANTED` | Separate explicit approval record, if later authorized |

## 7. Required future actions

The next allowed action is to preserve the exact HTML and metadata lock, assemble the source/version/provenance/rights evidence packet, and complete the owner-governed Emergency Medicine, Pharmacology/Drug Safety, metadata, technical/lineage, rights/provenance, and audit review streams. Each review must provide attributable identity or authority, actual review date/time, scope, cited locators, findings, conflicts, limitations, disposition, and audit linkage.

No medication content may be normalized, imported, corrected, activated, published, or exposed to learners from this record. No source may be set to `READY_FOR_NORMALIZATION`.

## 8. Controls and non-actions

```text
OWNER_REVIEW_DECISION = OWNER_REQUIRES_FURTHER_REVIEW
CURRENT_GATE = BLOCKED_PENDING_EVIDENCE
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
READY_FOR_NORMALIZATION = NOT_SET
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
CONTENT_MODIFIED = FALSE
CLINICAL_CORRECTNESS_CERTIFIED = FALSE
DRUG_SAFETY_CERTIFIED = FALSE
```

| Non-action | Result |
|---|---|
| External approval claimed | `NO` |
| Copyright/rights clearance claimed | `NO` |
| Clinical publication approval claimed | `NO` |
| Content correction performed | `NO` |
| Normalization/import/activation/publication performed | `NO` |
| Database/schema/application changed | `NO` |

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_METADATA_LOCK_RECORD.md "SEG Drug HTML Metadata Lock Record"

[2]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_CLOSURE_STATUS.md "SEG Drug HTML Closure Status"

[3]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_OWNER_REVIEW_RECORD.md "SEG Drug HTML Owner Review Record"

[4]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_AUTHORITY_POLICY.md "SEG Owner Review Authority Policy"

[5]: file:///home/ubuntu/seg-internship-output/SEG_P0_VERSION_CONTROL_REGISTER.md "SEG P0 Version Control Register"

**Document status:** `DRUG_HTML_MEDICAL_CLOSURE_RECORDED_REQUIRES_FURTHER_REVIEW`
